Gerry Campos, MD
Obstetrics & Gynecology · Quincy, MANPI 1376509703
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.4%), education and gifts — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Coloplast at 29.3% of the total. Reporting peaked in 2019 at $253 and has fallen 51.8% since, to $122 in 2025.
Across 14 payments — averaging $61.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$253
- Boston Scientific$220
- Intuitive Surgical$203
- AbbVie$112
- Teva Pharmaceuticals USA, Inc.$51
- Medtronic$24
What the payments were for
- Food & beverage$36642%
- Education$29534%
- Gifts$20323%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 2 | $253 |
| Boston Scientific | 3 | $220 |
| Intuitive Surgical | 1 | $203 |
| AbbVie(2 entities) | 5 | $112 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Medtronic | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESTORELLE$253
- Da Vinci Surgical System$203
- UPSYLON$123
How this compares
$864 in reported general payments places this provider in the 80th percentile of 910 obstetrics & gynecology providers in Massachusetts.
See all obstetrics & gynecology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 216 | $169,270 |
| MyrbetriqMirabegron | 84 | $68,296 |
| EstringEstradiol | 47 | $24,094 |
| Estradiol | 171 | $16,866 |
| Trospium Chloride ErTrospium Chloride | 61 | $12,985 |
| YuvafemEstradiol | 69 | $7,516 |
| Mirabegron ErMirabegron | 12 | $6,773 |
| Trospium Chloride | 99 | $5,790 |
| Trimethoprim | 61 | $3,980 |
| Methenamine Hippurate | 34 | $1,835 |
| Fosfomycin Tromethamine | 15 | $1,457 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 168 | $1,143 |
| NitrofurantoinNitrofurantoin Macrocrystal | 25 | $803 |
| Cefpodoxime Proxetil | 19 | $477 |
| Metronidazole | 14 | $239 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Quincy
- Amanda MetzgerQuincy$14K
- Soheil Amin HanjaniBrockton$386K
- Joelle LiemanBrighton$215K
- Elizabeth OnyemelukweBoston$135K
- James GreenbergBoston$119K
- Stephanie AlimenaBoston$75K
- Denis VaughanBoston$38K
- Lara KingstonPlymouth$37K
- Erica RobinsonWorcester$32K
- Roxanne GardnerBoston$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.